IPATF News and Press, ImmunoPrecise Antibodies Ltd. From 12/02/19

ImmunoPrecise Announces Annual General Meeting Results Canada NewsWire VICTORIA, Dec. 2, 2019 VICTORIA , Dec. 2, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) announces that all resolutions were passed by the s...

Talem Therapeutics accesses the OmniAb® platform from Ligand Pharmaceuticals Canada NewsWire VICTORIA, Nov. 5, 2019 VICTORIA , Nov. 5, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF), an industry leader in th...

ImmunoPrecise Adopts Shareholder Rights Plan Canada NewsWire VICTORIA, Oct. 18, 2019 VICTORIA , Oct. 18, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF), an industry leader in the discovery of novel, therapeutic antibo...

ImmunoPrecise Strengthens Board of Directors with Antibody Business Leader, Brian Lundstrom Canada NewsWire VICTORIA, Oct. 3, 2019 VICTORIA , Oct. 3, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of best-...

ImmunoPrecise Antibodies Appoints Biotech Industry Executive Dr. Stefan Lang as Chief Business Officer Canada NewsWire VICTORIA, Oct. 1, 2019 VICTORIA , Oct. 1, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) a pr...

ImmunoPrecise Antibodies ( OTCQB:IPATF ): Q1 GAAP EPS of -C$0.03. Revenue of C$2.71M (-5.6% Y/Y) Press Release More news on: ImmunoPrecise Antibodies Ltd., Earnings news and commentary, ,

ImmunoPrecise Antibodies Announces 95.7% Investors Favored Debenture Extension and Q1 2020 Financial Results Canada NewsWire VICTORIA, Sept. 30, 2019 VICTORIA , Sept. 30, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF)...

ImmunoPrecise's Talem Therapeutics Enters into an LOI with AgonOx Pharma in the Advancement of Novel, Immuno-Oncology Therapeutics Canada NewsWire VICTORIA, Sept. 24, 2019 VICTORIA , Sept. 24, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTUR...

ImmunoPrecise Launches Abthena™ Bispecific Platform And Artemis™ Intelligence Metadata (AIM) Canada NewsWire VICTORIA, Sept. 23, 2019 VICTORIA , Sept. 23, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF), ...

ImmunoPrecise Antibodies ( OTCQB:IPATF ): FY GAAP EPS of -C$0.12. More news on: ImmunoPrecise Antibodies Ltd., Earnings news and commentary, , Read more ...